Cegedim SA Market Share Analysis

Publisher Name :
Date: 12-Dec-2012
No. of pages: 31
Inquire Before Buying

Cegedim SA Market Share Analysis

Summary

GlobalData’s new report, “Cegedim SA Market Share Analysis” provides in-depth information on Cegedim SA.’s market position in the clinical IT systems market. The report also provides data and information on the overall competitive landscape within the clinical IT systems market. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Global company shares (in Revenues) information for the clinical IT systems market.
- Cegedim SA.’s company shares (in Revenues) information for all the key countries the company has presence in -United Kingdom and France.
- Cegedim SA.’s company shares (in Revenues) information for the clinical IT systems market.
- All the key data-points are for 2011 and cover all the key regions -Europe.
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.

Reasons to buy

- Develop sales and marketing strategies by identifying who-stands-where in the markets, Cegedim SA.’s operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Cegedim SA.’s market positions.

Cegedim SA Market Share Analysis

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
3 Definitions of Markets/Categories Covered 6
3.1 Healthcare IT 6
3.1.1 Clinical IT Systems 6
4 Company Snapshot 7
4.1 Key Facts 7
4.2 Company Overview 7
4.3 Financial Performance 7
4.4 Business Overview 8
4.5 Major Products and Services 8
4.5.1 Overview 8
5 History 9
6 Competitors 11
7 Competitive Landscape 13
7.1 Healthcare IT (Clinical IT Systems), Global, Market Share (%), 2011 13
7.2 Cegedim SA, Healthcare IT, Global, Market Share (2011) 15
7.3 Cegedim SA, Healthcare IT (Clinical IT Systems), by Country, Market Share (2011) 16
7.4 Key Employees 17
8 Key Employee Biographies 18
9 Company Statement 19
10 Locations And Subsidiaries 21
10.1 Head Office 21
10.2 Other Locations & Subsidiaries 21
11 Cegedim SA Detailed Deal Summary 23
11.1 Equity Offering 23
11.1.1 Cegedim Completes Rights Issue For $268.2 Million 23
11.2 Acquisition 24
11.2.1 Cegedim Acquires Pulse Systems 24
12 Recent Developments 25
12.1 Strategy And Business Planning 25
12.1.1 Jun 03, 2009: Cegedim Dendrite To Provide Mobile Intelligence CRM To Sanofi Aventis 25
13 Appendix 26
13.1 Research Methodology 27
13.2 Secondary Research 27
13.3 Primary Research 28
13.4 Models 28
13.5 Forecasts 28
13.6 Expert Panels 29
13.7 GlobalData Consulting 29
13.8 Currency Conversion 30
13.9 Contact Us 31
13.10 Disclaimer 31

1.1 List of Tables
Table 1: Cegedim SA, Key Facts, 2011 7
Table 2: Healthcare IT (Clinical IT Systems), Global, Company Share by Revenue ($m), 2011 14
Table 3: Cegedim SA, Healthcare IT, Clinical IT Systems, Global, Revenue ($m) and Market Share (%), 2011 15
Table 4: Cegedim SA, Anesthesia and Respiratory Devices (Clinical IT Systems), by Country, Revenue ($m) and Market Share (%), 2011 16
Table 5: Cegedim SA, Key Employees 17
Table 6: Cegedim SA, Other Locations 21
Table 7: Cegedim SA, Subsidiaries 22
Table 8: Cegedim Completes Rights Issue For $268.2 Million 23
Table 9: Cegedim Acquires Pulse Systems 24
Table 10: USD to Local Currency, Average Exchange Rate, 2011 30

1.2 List of Figures
Figure 1: Healthcare IT (Clinical IT Systems), Global, Market Share (%), 2011 13
Figure 2: Cegedim SA, Healthcare IT (Clinical IT Systems), by Country, Market Share (%), 2011 16
  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Kazakhstan Pharmaceuticals and Healthcare Report Q4 2014
    Published: 17-Sep-2014        Price: US $1295 Onwards        Pages: 93
    BMI View: Kazakhstan's healthcare sector suffers from a lack of trained medical professionals and the inherent difficulties of providing infrastructure and access to healthcare in such a large country. However, the government continues to show its commitment to improving healthcare as it allocates more funds to constructing new health clinics across the country. Although Kazakhstan's growing pharmaceutical industry will be driven by demand for generic medicines over the medium term, we believe t......
  • Myanmar Pharmaceuticals and Healthcare Report Q4 2014
    Published: 17-Sep-2014        Price: US $1295 Onwards        Pages: 61
    BMI View: While the current medical gap will attract some foreign investors into Myanmar, we highlight that the lack of basic infrastructure and political instability will potentially affect the growth of the economy. Headline Expenditure Projections ? Pharmaceutical sales: MMK324.8bn (USD350mn) in 2013 to MMK387.5bn (USD390mn) in 2014; +19.3% in local currency terms and +11.3% in US dollar terms. Forecast unchanged from previous quarter. ? Healthcare Expenditure: MMK1,047.3bn (USD1.1bn) in 2013......
  • Slovenia Pharmaceuticals and Healthcare Report Q4 2014
    Published: 17-Sep-2014        Price: US $1295 Onwards        Pages: 91
    BMI View: Slovenia is facing deflationary pressures on consumer prices, which will impact pharmaceutical spending - especially as an increasing proportion of high-value drugs is met by co-payments. We have therefore downwardly revised our pharmaceutical forecast for 2014. A high budget deficit limits room for the new government to increase funding for health services, and we expect healthcare spending to decline this year and next, before returning to modest growth in 2016. Headline Expenditure ......
  • United States Pharmaceuticals and Healthcare Report Q4 2014
    Published: 17-Sep-2014        Price: US $1295 Onwards        Pages: 122
    BMI View: The US pharmaceutical market presents strong commercial opportunities across the industry. Total US pharmaceutical sales reached USD347.2bn in 2013 - more than three times the size of its nearest rival Japan. The US boasts the largest individual markets across the three core sub-sectors: patented, generic and over-the-counter medicines. State-level pharmaceutical markets in the country are larger than many country-level pharmaceutical markets. Headline Expenditure Projections ? Pharmac......
  • Research Report on China Foot-and-mouth Disease (FMD) Vaccine Industry, 2014-2018
    Published: 17-Sep-2014        Price: US $1800 Onwards        Pages: 50
    China is the world's largest producer and consumer of pork with the output volume accounting nearly 50% of the total. According to the statistics of agricultural production from the National Bureau of Statistics of China, the annual output volume of poultry meat was 83.73 million tons in 2013, up by 1.8% YOY. The output volume of pork was 54.93 million tons, up by 2.8%. The stock volume of hogs was 474.11 million, down by 0.4% compared to 2012. The stock volume of fattened hogs was 715.57 millio......
  • Research Report on China Swine Fever Vaccine Industry, 2014-2018
    Published: 17-Sep-2014        Price: US $1800 Onwards        Pages: 50
    China is the world's largest producer and consumer of pork with the output volume accounting nearly 50% of the total. The output volume of pork was 54.93 million tons in China in 2013, up by 2.8% YOY. The livestock volume of pigs was 474.11 million, down by 0.4% YOY while the stock volume of fattened pigs was 715.57 million, up by 2.5% YOY. Swine fever is considered a highly infectious disease that needs strict prevention, control and extermination. The swine fever vaccine is one of the neces......
  • Austria Pharmaceuticals and Healthcare Report Q4 2014
    Published: 17-Sep-2014        Price: US $1295 Onwards        Pages: 68
    BMI View: BMI has upwardly revised its pharmaceutical and healthcare forecasts for Austria, reflecting the country's improving economic prospects and attractiveness of these sectors in particular. The United States Commerce department has listed Austria as one of the most attractive countries in which to market healthcare technologies, while one of its domestic pharmaceutical firms has announced success in developing a cure for Alzheimer's. We believe that this would spur inward investment in th......
  • Research Report on China Avian Influenza Vaccine Industry, 2014-2018
    Published: 17-Sep-2014        Price: US $1800 Onwards        Pages: 50
    Many countries choose to kill all infected poultry to control avian influenza, instead of immunizations. The total number of poultry exceeds 10 billion in China. Epidemic diseases, which are difficult to control, will result in huge losses. Therefore, it is quite necessary to immunize the poultry with avian influenza vaccines. Avian influenza vaccines have been used for more than 10 years in China. Some poultry farms in China began to use H5N1 avian influenza vaccines voluntarily 10 years ago......
  • Bangladesh Pharmaceuticals and Healthcare Report Q4 2014
    Published: 17-Sep-2014        Price: US $1295 Onwards        Pages: 110
    BMI View: We consider Bangladesh's commitment to another round of spending on the development of healthcare, information technology, infrastructure, energy production, education, agriculture and food security and transportation in fiscal year 2014/2015 as a sound investment. While we are optimistic that ongoing tax reform efforts by the government will rake in more revenues to support development spending, and keep the country's budget deficit manageable at around 3.0% of GDP over the coming yea......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs